Better Adherence to Antipsychotics Linked to Lower Vehicle Crash Risk
By Elana Gotkine HealthDay Reporter
MONDAY, June 9, 2025 -- For drivers with schizophrenia, better adherence to antipsychotic medications is associated with lower motor vehicle crash risk, according to a study published online June 9 in CMAJ, the journal of the Canadian Medical Association.
John A. Staples, M.D., M.P.H., from the University of British Columbia in Vancouver, Canada, and colleagues performed a case-crossover study using population-based administrative health and driving data from British Columbia to examine whether antipsychotic adherence reduces the risk for a motor vehicle crash among individuals with schizophrenia. The study included individuals with schizophrenia who were involved as a driver in a police-attended motor vehicle crash during 2001 to 2016 and who filled prescriptions for antipsychotic medication as an outpatient in the two years before the crash; data were included for 1,130 eligible motor vehicle crashes.
The researchers found that the mean antipsychotic medication possession ratio was 0.69 in the 30 days before the crash (precrash interval) and 0.76 in the control interval (30-day interval ending one year before the crash). Relative to complete nonadherence, perfect adherence to antipsychotic medication was associated with half the odds of a crash (adjusted odds ratio, 0.50). Among subgroups defined by sex, age, and history of alcohol or drug use, the findings were consistent.
"Our results provide one more reason for doctors and family members to encourage people with schizophrenia to take their antipsychotics as prescribed," Staples said in a statement. "We think our results also suggest that health systems should put more resources into programs to support antipsychotic adherence among people with schizophrenia."
One author disclosed consulting for Boehringer Ingelheim, AbbVie, Newron, and Otsuka.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
Most People With Cannabis Use Disorder Remain Untreated
MONDAY, June 9, 2025 -- Most individuals in the United States with cannabis use disorder (CUD) do not receive treatment, according to a study published online May 19...
Early Dog Exposure May Modify Genetic Effect on Atopic Eczema Risk
MONDAY, June 9, 2025 -- Early-life dog exposure may modify the genetic effect of the single nucleotide variant rs10214237 on atopic eczema (AE) via IL7R, according to a study...
Drop in Mental Health Scores Seen With Primary Open-Angle Glaucoma Diagnosis
MONDAY, June 9, 2025 -- Diagnosis of primary open-angle glaucoma (POAG) is associated with a reduction in mental health scores, according to a study published online June 5 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.